| Literature DB >> 30988996 |
Vafa Baradaran Rahimi1,2, Farideh Ajam2, Hasan Rakhshandeh2, Vahid Reza Askari2,3.
Abstract
Portulaca oleracea L. (PO) or Purslane is an annual grassy plant that is distributed in many parts of the world, especially the tropical and subtropical areas. PO has some pharmacological properties such as analgesic, antibacterial, skeletal muscle-relaxant, wound-healing, anti- inflammatory and a radical scavenger. This review article is focused on the anti-inflammatory, immuno-modulatory, anti-oxidant and anti-tumor activities of the PO. Anti-inflammatory, immuno-modulatory, anti-oxidant and Anti-tumor effects of PO were searched using various databases until the end of August 2018. The online literature was searched using PubMed, Science Direct, Scopus, Google Scholar and Web of Science. Our review showed that PO exerts its effects through anti-inflammatory properties and balancing the adaptive and innate immune system depending on situations. PO acts as immune-modulator and anti-oxidant agent in both inflammatory states by the dominance of Th2 response such as asthma, cancer and atopic dermatitis and evoked Th1 disorders including hepatitis and multiple sclerosis.Entities:
Keywords: Portulaca oleracea; immuno-modulation; inflammation; purslane
Year: 2019 PMID: 30988996 PMCID: PMC6461301 DOI: 10.3831/KPI.2019.22.001
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Figure 1Chemical Constituents of PO
Summary of the anti-inflammatory effects of Portulaca oleracea.
| Type of extract or constituents | Study model | Result | Ref. |
|---|---|---|---|
| Oleracone and oleracimine | LPS-stimulated macrophages | Diminished the secretion of IL-6, TNF-α, NO, prostaglandin E2, mRNA cyclooxygenase 2 and inducible nitric oxide synthase | |
| 90% ethanolic macerated PO extract | LPS-stimulated AGS gastric cancer cells | Decreased TNF-α and IL-1β mRNA expression | |
| PO aqueous extract | HUVECs cells | Suppressed the TNF-α-induced ROS over-production, overexpression of ICAM-1, VCAM-1, E- selectin, IL-8, MCP-1, translocation of NF-κB to the nucleus and NF-κB binding. Prevented the adhesion of HL-60 cells to TNF-α-induced HUVECs. | |
| PO 80% ethanolic extract | hypoxia-induced pulmonary edema in mouse | Reduced the vascular permeability, NF-κB up-regulation, the levels of IL-1β, TNF-α, ICAM-1, VCAM-1, and P-selectin | |
| CPOP | Streptozotocin-induced diabetes in the rat | Alleviated TNF-α, IL-6, SOD and MDA levels |
Summary of the anti-oxidant effects of Portulaca oleracea.
| Type of extract or constituents | Study model | Result | Ref. |
|---|---|---|---|
| Saline-induced stress in plant | Showed anti-oxidant properties and protect the plant. | ||
| adult male Waster albino rats | Reduced the liver function tests (ALT, AST, γ-GT, and ALP) and kidney function tests (the levels of urea, serum creatinine, and blood urea nitrogen). Augmented the levels of SOD, CAT, GPx, GST, GR, GSH as well as diminished MDA and NO in liver, kidney, and testis of rats. | ||
| D-galactose induced aging in female mice | Decreased the LH and FSH level and MDA content. Increased estrogen and progesterone levels as well as SOD and CAT activities. | ||
| Horse oil lipids and HeLa, Eca-109 and MCF-7 cells | In-vitro anti-oxidant activity. Inhibits the oxidation of horse oil lipids during storage. Prevented tumor cell growth in HeLa, Eca-109 and MCF-7 cells. | ||
| Streptozotocin-induced diabetes in the rat | Reduced the MDA and SOD activities in the liver tissue | ||
| OVA+ A1 (OH) 3 -induced asthma in rats | Mitigated the NO2, NO3, and MDA, serum levels, total WBC number and percentage of eosinophils and neutrophils. Propagated SOD, CAT and thiol levels. | ||
| H2O2- induced DNA damage in human lymphocytes | Aqueous extract of PO inhibited DNA damage by comet assay, while this effect was not present in its ethanolic extract. |
Summary of the immuno-modulatory effects of Portulaca oleracea.
| Type of extract or constituents | Study model | Result | Ref. |
|---|---|---|---|
| BALB/c-isolatcd splenocytes | Inhibited the proliferation induced by concanavalin A in BALB/c-isolated splenocytes | ||
| PHA-stimulated human lymphocytes | Attenuated the percentage of cell proliferation, NO production and the levels of IL-4, IL10, and IFN-γ. | ||
| Human white blood cells Peyer’s patch (PP) cells from the small intestine of mice | Stimulated CD4+, CD25+ cells. Activated phagocytes Enhanced IL-6 produced from white blood cells. Intestinal immuno-modulatory activities by interacting with immune cells in Peyer’s patch cells. | ||
| MNNG -induced gastric cancer in rats | Appended SOD, CAT, GSH-Px, IL-2, IL-4 and TNF-α levels. | ||
| Asthmatic rats | Attenuates the levels of total protein, PLA2, and IgE in BALF | ||
| Hyper-cholesterolemic rats | Mitigates the lipid parameters. Improves IgG and IgM levels. | ||
| Cyclophosphamide-induced immuno-suppression in mice | Elevated phagocytosis and higher proliferative response in splenic lymphocytes. |
Summary of the anti-tumor effects of Portulaca oleracea.
| Type of extract or constituents | Study model | Result | Ref. |
|---|---|---|---|
| Tumor-bearing sarcoma 180 mouse | Enhanced the amount of CD4+ T lymphocytes, WBC numbers and the ratio of CD4 (+)/CD8 (+). Decreased the tumor growth, AST, ALT, BUN, and creatinine levels. | ||
| HepG2 cells | Mitigates the HepG2 cell viability, typical morphology and adhesion capacity of HepG2 cells. | ||
| Rats with ovarian cancer | Scavenge DPPH, NO and hydroxyl radicals. Prevented the RBC hemolysis as well as propagated the spleen, thymocyte T and B lymphocyte proliferation. | ||
| HepG2 and HeLa cancer cell lines | Suppressed the growth of HeLa and HepG2 cells. | ||
| Human liver cancer HCCLM3 cells | Reduces the viability. Elevated the percentage of apoptotic cells, the phosphorylation of p38 MAPK and JNK, the release of mitochondrial cytochrome c and AIF to the cytosol as well as activation of caspase-9 and caspase-3. |